Milk antibody response after 3rd dose of COVID-19 mRNA vaccine and SARS-CoV-2 breakthrough infection and implications for infant protection
Yarden Golan, Mikias Ilala, Caryl Gay, Soumya Hunagund, Christine Y. Lin, Arianna G. Cassidy, Unurzul Jigmeddagva, Lin Li, Nida Ozarslan, Ifeyinwa V. Asiodu, Nadav Ahituv, Valerie J. Flaherman, Stephanie L. Gaw, Mary Prahl
doi: https://doi.org/10.1101/2022.12.12.22283367
Yarden Golan
1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, and Institute for Human Genetics, University of California, San Francisco, California, United States of America
Ph.D.Mikias Ilala
2Department of Pediatrics, University of California, San Francisco, California, United States of America
3Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, United States of America
Caryl Gay
4Department of Family Health Care Nursing, University of California, San Francisco, California, United States of America
Ph.D.Soumya Hunagund
5Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
Christine Y. Lin
5Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
Arianna G. Cassidy
5Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
M.D.Unurzul Jigmeddagva
6Center for Reproductive Sciences, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
M.D.Lin Li
5Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
6Center for Reproductive Sciences, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
M.D., Ph.D.Nida Ozarslan
5Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
M.D.Ifeyinwa V. Asiodu
4Department of Family Health Care Nursing, University of California, San Francisco, California, United States of America
Ph.D, R.N.Nadav Ahituv
1Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, and Institute for Human Genetics, University of California, San Francisco, California, United States of America
Ph.D.Valerie J. Flaherman
2Department of Pediatrics, University of California, San Francisco, California, United States of America
M.D., M.P.H.Stephanie L. Gaw
5Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
6Center for Reproductive Sciences, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, California, United States of America
M.D., Ph.D.Mary Prahl
2Department of Pediatrics, University of California, San Francisco, California, United States of America
7Division of Pediatric Infectious Diseases and Global Health, University of California, San Francisco, California, United States of America
M.D.Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted December 14, 2022.
Milk antibody response after 3rd dose of COVID-19 mRNA vaccine and SARS-CoV-2 breakthrough infection and implications for infant protection
Yarden Golan, Mikias Ilala, Caryl Gay, Soumya Hunagund, Christine Y. Lin, Arianna G. Cassidy, Unurzul Jigmeddagva, Lin Li, Nida Ozarslan, Ifeyinwa V. Asiodu, Nadav Ahituv, Valerie J. Flaherman, Stephanie L. Gaw, Mary Prahl
medRxiv 2022.12.12.22283367; doi: https://doi.org/10.1101/2022.12.12.22283367
Milk antibody response after 3rd dose of COVID-19 mRNA vaccine and SARS-CoV-2 breakthrough infection and implications for infant protection
Yarden Golan, Mikias Ilala, Caryl Gay, Soumya Hunagund, Christine Y. Lin, Arianna G. Cassidy, Unurzul Jigmeddagva, Lin Li, Nida Ozarslan, Ifeyinwa V. Asiodu, Nadav Ahituv, Valerie J. Flaherman, Stephanie L. Gaw, Mary Prahl
medRxiv 2022.12.12.22283367; doi: https://doi.org/10.1101/2022.12.12.22283367
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12603)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)